Vivos Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VVOS research report →
About the company
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
- CEO
- R. Kirk Huntsman
- IPO
- 2020
- Employees
- 105
- HQ
- Littleton, CO, US
Price Chart
- Market Cap
- $2.67M
- P/E
- -0.20
- P/S
- 0.14
- P/B
- -5.83
- EV/EBITDA
- -0.55
- Div Yield
- 0.00%
- Gross Margin
- 59.48%
- Op Margin
- -115.47%
- Net Margin
- -128.36%
- ROE
- -2239.18%
- ROIC
- -148.61%
- Revenue
- $17.44M · 16.05%
- Net Income
- $-21,230,000 · -90.64%
- EPS
- $-2.06 · 7.21%
- Op Income
- $-19,894,000
- FCF YoY
- -32.77%
- 52W High
- $7.95
- 52W Low
- $0.38
- 50D MA
- $0.65
- 200D MA
- $1.71
- Beta
- 6.08
- Avg Volume
- 1.73M
Get TickerSpark's AI analysis on VVOS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 31, 26 | V-Co Investors 3 LLC | other | 0 |
| Mar 31, 26 | V-Co Investors 3 LLC | other | 429,957 |
| Mar 31, 26 | V-Co Investors 3 LLC | other | 1,783,582 |
| Mar 31, 26 | V-Co Investors 3 LLC | other | 1,783,582 |
| Mar 31, 26 | Skaff Michael C | buy | 1,783,582 |
| Mar 31, 26 | Skaff Michael C | buy | 1,783,582 |
| Mar 31, 26 | Skaff Michael C | buy | 308,848 |
| Mar 31, 26 | Skaff Michael C | buy | 1,044,777 |
| Mar 31, 26 | Skaff Michael C | buy | 429,957 |
| Feb 4, 26 | JOHNSON GREGG C | other | 0 |
Our VVOS coverage
Recent articles, reports, and earnings notes.
No research on VVOS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VVOS report →Similar companies
Peers in the same neighborhood.